BioLink Life Sciences, Inc.   Report issue

For profit
Founded: Cary NB United States (2001)

Organization Overview

First Clinical Trial
2017
NCT03761979
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

BioLink Life Sciences, Inc.

Active Ingredients

Drugs in Other Trials (1)

strontium l-lactate (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1